🔬 The acquisition allows CatSci to offer holistic chromatographic services to its global customers.
🌍 Reach Separations, based in the UK, provides a range of screening options using SFC and HPLC instrumentation.
💡 CatSci aims to enhance its CMC capabilities and add strategic value to its customer partnerships.
💼 The acquisition will provide customers with end-to-end coverage of the analytical development lifecycle.
Introduction:
CatSci, a U.K.-based company, has acquired Reach Separations, a specialist chromatography provider. The acquisition will allow CatSci to offer its global customers holistic chromatographic services, aiding them from discovery to manufacture. This enhanced separation science offering will support the analysis of small molecules, oligonucleotides, and other complex synthetic medicines.
- The acquisition of Reach Separations will enable CatSci to provide its customers with comprehensive chromatographic services.
- Reach Separations specializes in chromatography for the analysis and purification of chiral and achiral therapeutics.
- CatSci’s acquisition of Reach will enhance its CMC capabilities and add strategic value to its partnerships with customers.
- Reach’s screening options, including supercritical fluid chromatography (SFC) and high-performance liquid chromatography (HPLC), will benefit CatSci’s customers in solving complex analytical problems.
- This acquisition will allow CatSci to offer end-to-end coverage of the analytical development lifecycle, from discovery to GMP manufacture.
Conclusion:
CatSci’s acquisition of Reach Separations will expand its chromatographic capabilities and provide its global customers with comprehensive analytical and purification services. This acquisition aligns with CatSci’s growth strategy and will add strategic value to its partnerships with customers. The integrated technologies and expertise of both companies will create a one-stop-shop for analysis and purification, facilitating the development of new therapeutics.
